Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Hilton’s advertising campaigns showcase luxury, ambition, and unique experiences, reveals GlobalData

Hilton Worldwide Holdings Inc’s (Hilton) advertising initiatives from February to July 2025 emphasize a focus on travelers seeking luxury, personalized service, and unique experiences. By showcasing properties like the iconic Waldorf Astoria and the vibrant Hilton Cancun Mar Caribe, these ads resonate with diverse audiences, including business travelers and luxury seekers. The campaigns reflect a […]
Read more

Four drugs in race for first bispecific ADC approval, reveals GlobalData

Bispecific (bs) antibody drug conjugates (ADCs) are an emerging therapeutic approach that presents advantages over traditional ADCs. With 84% of bsADCs in the preclinical or discovery stages, the pipeline is still nascent. However, with four candidates in Phase III, the race for the first approval in this novel landscape is underway, according to GlobalData, a […]
Read more

Semaglutide patent cliff to present substantial opportunity for companies in the Chinese generics market, says GlobalData

Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, ranked among the top-selling drugs globally in 2024. While patents protect the drug until 2031-2032 in seven major markets, China’s patent expires much earlier, in March 2026. Chinese pharmaceutical companies are aggressively preparing their manufacturing capabilities and regulatory approvals to capitalize on this multi-billion-dollar market […]
Read more

Agentic AI will take business and industrial automation to new heights, says GlobalData

Agentic AI holds much promise for improving the efficiency of enterprise workflows, reducing costs, and improving customer experience. Able to communicate and collaborate, AI agents are being developed for a wide range of consumer, enterprise, scientific, and industrial purposes. Highly complex environments, such as industrial plants or hospitals, might be served by an orchestration of […]
Read more

India VC funding activity shows resilience with notable growth during January-July 2025, finds GlobalData

India’s venture capital (VC) funding landscape has demonstrated resilience in 2025, showcasing an uptick in both deal volume and deal value. The total number of VC deals announced in the country increased by around 14% during January-July 2025 compared to the same period in the previous year, while the corresponding deal value registered a year-on-year […]
Read more

APAC deal activity up 3% YoY during January-July 2025, other regions experience decline, finds GlobalData

The Asia-Pacific (APAC) deal landscape (comprising mergers & acquisitions (M&A), private equity and venture financing deals) has showcased relative resilience amid declines experienced in other regions during the first seven months of 2025 compared to the same period in the previous year. The total number of deals announced in the APAC region increased by around […]
Read more

US eosinophilic esophagitis market to reach $1.19 billion by 2030, forecasts GlobalData

The US eosinophilic esophagitis (EoE) market is projected to grow from $202 million in 2020 to $1.19 billion in 2030, registering a compound annual growth rate (CAGR) of 19.4%, driven by the transition from off-label therapies to FDA-approved, patient-friendly options such as Sanofi/Regeneron’s Dupixent (dupilumab), Takeda’s Eohilia (budesonide oral suspension), and Ellodi Pharmaceuticals’ late-stage pipeline […]
Read more

China to lead global methylene diphenyl diisocyanate capacity additions through 2030, says GlobalData

China is poised to significantly expand its methylene diphenyl diisocyanate (MDI) production capacity by 2030, driven by heavy demand for MDI from various sectors such as construction, automotive and electronics industries. Accounting for 65% of the expected capacity additions worldwide by 2030, China is further strengthen its position as the leading player in the global […]
Read more

PET agents gain momentum as SPECT holds strong in nuclear medicine, says GlobalData

Though single-photon emission computed tomography (SPECT) remains the dominant modality for nuclear imaging globally, positron emission tomography (PET) imaging is gaining momentum, particularly in oncology and other high-value applications, primarily driven by tracer innovation, says GlobalData, a leading data and analytics company. According to GlobalData’s recently updated “Nuclear Imaging Agents” market model, the global PET […]
Read more

Brokers rank Aviva top for majority of services in commercial insurance, finds GlobalData

Aviva received high praise from brokers, leading the market in 10 of the 12 categories including underwriting flexibility, digital capabilities, and AI integration, which are essential elements in the fast-changing insurance landscape, according to the 2025 UK Commercial Insurance Broker Survey by GlobalData, a leading data and analytics company. Aviva, Allianz, AXA, and Zurich consistently […]
Read more

Global HVDC converter stations market to record aggregate value of $75.34 billion during 2025-30, forecasts GlobalData

The global high-voltage direct current (HVDC) converter stations market is undergoing significant growth, propelled by the escalating demand for electricity, advancements in smart grid technology, and substantial investments in power infrastructure. With notable contributions from China, Germany, the US, India, the UK, South Korea, and Italy, the market is projected to reach an aggregate value […]
Read more
1 … 30 31 32 33 34 … 136